Tahithromos’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$12.9M Hold
160,000
17.91% 2
2017
Q4
$11.4M Hold
160,000
14.64% 2
2017
Q3
$11.6M Hold
160,000
14.03% 2
2017
Q2
$10.6M Hold
160,000
11.27% 2
2017
Q1
$9.52M Hold
160,000
12% 2
2016
Q4
$8.96M Buy
+160,000
New +$8.56M 10.73% 2
2015
Q3
Sell
-32,500
Closed -$1.99M 18
2015
Q2
$1.99M Buy
+32,500
New +$2.04M 2.73% 10
2014
Q2
Sell
-150,000
Closed -$7.59M 42
2014
Q1
$7.59M Buy
150,000
+30,000
+25% +$1.5M 1.82% 21
2013
Q4
$6.06M Sell
120,000
-10,000
-8% -$455K 1.36% 26
2013
Q3
$5.34M Buy
+130,000
New +$4.83M 0.91% 37

Other funds holding CTSH

Tahithromos's CTSH Position: Q1 2018 in Review

Tahithromos held its Cognizant (CTSH) position steady in Q1 2018 at 160,000 shares worth $12.9M. The position accounts for 17.91% of the portfolio, ranked #2.

Tahithromos first reported a position in CTSH in Q3 2013 and has held it in 10 quarters since. 1,045 funds tracked by Wall St. Rank hold CTSH as of Q1 2018.

  • Tahithromos held 160,000 shares of Cognizant worth $12.9M as of Q1 2018.
  • Tahithromos left its Cognizant share count unchanged in Q1 2018.
  • Cognizant made up 17.91% of Tahithromos's portfolio in Q1 2018, its #2 holding.
  • Tahithromos first reported a position in Cognizant in Q3 2013 and has held it in 10 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Cognizant as of Q1 2018.

Based on Tahithromos's 13F filing for Q1 2018, filed 9 May 2018.